This is new.
A Daffodil trial has now been added to the Lavender and Lilac trials.
Daffodil is an open-label study of trofinetide for the treatment of girls two to five years of age who have Rett syndrome.
Ten participants, measuring safety and tolerability over two years.
https://clinicaltrials.gov/ct2/show/NCT04988867
Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-32
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.89 |
Change
-0.070(0.54%) |
Mkt cap ! $1.602B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.02 | $12.70 | $912.3K | 71.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 188 | $12.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.89 | 301 | 5 |
View Market Depth
| Last trade - 10.49am 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |